Enfusion, Inc. (ENFN)
After hours:
| Previous Close | 8.07 |
| Open | 8.13 |
| Bid | 7.81 x 1100 |
| Ask | 8.31 x 900 |
| Day's Range | 8.07 - 8.24 |
| 52 Week Range | 7.52 - 10.45 |
| Volume | |
| Avg. Volume | 370,054 |
| Market Cap | 765.26M |
| Beta (5Y Monthly) | 0.90 |
| PE Ratio (TTM) | 205.25 |
| EPS (TTM) | 0.04 |
| Earnings Date | Nov 05, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.25 |
Simply Wall St.High Growth Tech Stocks In The United States To Watch
Over the last 7 days, the market has dropped 3.4%, but it has risen by 20% in the last year with earnings forecast to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks that can capitalize on these trends is crucial for investors looking to maximize their returns.
ZacksImplied Volatility Surging for Enfusion (ENFN) Stock Options
Investors need to pay close attention to Enfusion (ENFN) stock based on the movements in the options market lately.
Insider MonkeyShould You Believe in Enfusion’s (ENFN) Healthy Revenue Growth And Margin Expansion in the Future?
Next Century Growth Investors, LLC, an investment Management Company, released its “Small Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here. The equities market in 2024 saw mixed results in the second quarter. Small-cap indices generally posted negative results, whereas large-cap indices posted favorable results. The strategy returned (3.32)% […]
